BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29773865)

  • 1. Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle.
    Yamashita Y; Nakada S; Yoshihara T; Nara T; Furuya N; Miida T; Hattori N; Arikawa-Hirasawa E
    Sci Rep; 2018 May; 8(1):7766. PubMed ID: 29773865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.
    Xu Z; Ichikawa N; Kosaki K; Yamada Y; Sasaki T; Sakai LY; Kurosawa H; Hattori N; Arikawa-Hirasawa E
    Matrix Biol; 2010 Jul; 29(6):461-70. PubMed ID: 20541011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.
    Sadatsuki R; Kaneko H; Kinoshita M; Futami I; Nonaka R; Culley KL; Otero M; Hada S; Goldring MB; Yamada Y; Kaneko K; Arikawa-Hirasawa E; Ishijima M
    J Orthop Res; 2017 Apr; 35(4):837-846. PubMed ID: 27238423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perlecan-deficient mutation impairs corneal epithelial structure.
    Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial perlecan is required for osteophyte formation in knee osteoarthritis.
    Kaneko H; Ishijima M; Futami I; Tomikawa-Ichikawa N; Kosaki K; Sadatsuki R; Yamada Y; Kurosawa H; Kaneko K; Arikawa-Hirasawa E
    Matrix Biol; 2013 Apr; 32(3-4):178-87. PubMed ID: 23339896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate of perlecan is involved in glomerular filtration.
    Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
    J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
    Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
    Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
    Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
    Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan Facilitates Neuronal Nitric Oxide Synthase Delocalization in Denervation-Induced Muscle Atrophy.
    Nakada S; Yamashita Y; Machida S; Miyagoe-Suzuki Y; Arikawa-Hirasawa E
    Cells; 2020 Nov; 9(11):. PubMed ID: 33238404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
    Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
    Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the heparan sulfate proteoglycan perlecan on human disease and health.
    Arikawa-Hirasawa E
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1117-C1122. PubMed ID: 35417267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
    Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
    Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
    Shu CC; Smith SM; Little CB; Melrose J
    Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
    Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
    Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heparan sulphate deficient Hspg2 exon 3 null mouse displays reduced deposition of TGF-β1 in skin compared to C57BL/6 wild type mice.
    Shu C; Smith SM; Melrose J
    J Mol Histol; 2016 Jun; 47(3):365-74. PubMed ID: 27098652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.
    Nakamura K; Ikeuchi T; Nara K; Rhodes CS; Zhang P; Chiba Y; Kazuno S; Miura Y; Ago T; Arikawa-Hirasawa E; Mukouyama YS; Yamada Y
    J Cell Biol; 2019 Oct; 218(10):3506-3525. PubMed ID: 31541017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
    Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
    Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.
    Thompson WR; Modla S; Grindel BJ; Czymmek KJ; Kirn-Safran CB; Wang L; Duncan RL; Farach-Carson MC
    J Bone Miner Res; 2011 Mar; 26(3):618-29. PubMed ID: 20814969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIDE gene expression in adipose tissue, liver, and skeletal muscle from obese and lean pigs.
    Qiu YQ; Yang XF; Ma XY; Xiong YX; Tian ZM; Fan QL; Wang L; Jiang ZY
    J Zhejiang Univ Sci B; 2017 Jun; 18(6):492-500. PubMed ID: 28585425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.